First Results of a Head-to-Head Trial of Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia

Byrd J. C., Hillmen P., Ghia P., Kater A. P., Chanan-Khan A., Furman R. R., ...Daha Fazla

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, cilt.21, 2021 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Özet
  • Cilt numarası: 21
  • Basım Tarihi: 2021
  • Dergi Adı: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
  • Anahtar Kelimeler: CLL, acalabrutinib, ibrutinib, chronic lymphocytic leukemia, Bruton tyrosine kinase
  • İstanbul Üniversitesi Adresli: Evet